LBA29_PRAFATINIB VERSUS METHOTREXATE (MTX) AS SECOND-LINE...

Annals of Oncology 2014 / 09 Vol. 25; Iss. suppl_4

LBA29_PRAFATINIB VERSUS METHOTREXATE (MTX) AS SECOND-LINE TREATMENT FOR PATIENTS WITH RECURRENT AND/OR METASTATIC (R/M) HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) WHO PROGRESSED AFTER PLATINUM-BASED THERAPY: PRIMARY EFFICACY RESULTS OF LUX-HEAD & NECK 1, A PHASE III TRIAL

Machiels, J-P., Haddad, R.I., Fayette, J., Licitra, L.F., Tahara, M., Vermorken, J.B., Clement, P.M., Gauler, T., Cupissol, D., Grau, J.J., Guigay, J., Caponigro, F., De Castro, G., De Souza Viana, L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu438.30
Date:
September, 2014
File:
PDF, 74 KB
2014
Conversion to is in progress
Conversion to is failed